Greedy Insider
SOPHiA GENETICS SA (SOPH) Insider Trades and Scores
SOPHiA GENETICS SA (SOPH) insider trades: since Mar 19, 2026, Greedy Insider recorded 11 open-market buys and 150 sales on Form 4 from 14 insiders. The strongest recent filing scored 94 (Strong).
Who bought and who sold
Across the last 161 scoreable Form 4 transactions in SOPH, 11 were open-market purchases and 150 were sales. The table lists the most recent filings with each one's Greediness Score, so the structurally unusual trades are easy to spot first.
| Insider | Role | Type | Shares | Date | Score | ||
|---|---|---|---|---|---|---|---|
| Xu Zhenyu | Chief Scientific Officer | Sell | 4000.0 | 28727.2 | 2026-10-13 | 77 | View |
| Camblong Jurgi | Chair | Sell | 8500.0 | 61670.9 | 2026-10-12 | 82 | View |
| Menu Philippe | Chief Medical Officer | Sell | 5000.0 | 36303.0 | 2026-10-12 | 88 | View |
| Puylaert Kevin | Chief Sales Officer | Sell | 31.0 | 245.52 | 2026-10-05 | 79 | View |
| Verma Abhimanyu | Chief Technology Officer | Sell | 5284.0 | 42928.8 | 2026-10-05 | 86 | View |
| Puylaert Kevin | Chief Sales Officer | Sell | 185.0 | 1491.1 | 2026-10-05 | 92 | View |
| Valente Manuela | Chief People Officer | Sell | 4240.0 | 34487.312 | 2026-10-05 | 88 | View |
| CARDOZA GEORGE | CFO | Sell | 1592.0 | 12897.429 | 2026-10-05 | 76 | View |
| Menu Philippe | Chief Medical Officer | Sell | 7394.0 | 60099.91 | 2026-10-05 | 91 | View |
| Camblong Jurgi | Chair | Sell | 40172.0 | 326526.06 | 2026-10-05 | 94 | View |
The strongest recent filing
Camblong Jurgi (Chair) sold 40,172 shares of SOPHiA GENETICS SA on Oct 5, 2026, a filing that scored 94 (Strong). It scored Strong because a senior insider was trading and several insiders moved the same way within a week. The score describes the filing, not future returns. This is not investment advice.
Cluster activity
A cluster buy is present: 9 insiders (Camblong Jurgi, Menu Philippe, Puylaert Kevin, Verma Abhimanyu) traded SOPH the same direction within a 7-day window. Shared conviction is a stronger structural signal than a lone trade.
How this compares with SOPHiA GENETICS SA's own history
Open-market buys make up 7% of the 161 scoreable SOPH transactions on record between Mar 19, 2026 and Oct 13, 2026. Comparing a filing with the company's own buy/sell mix is how you tell a routine disposal from an unusual accumulation.
Methodology and sources
Scores come from six published, user-adjustable factors (insider role, cluster activity, trade size versus the insider's own history, position impact, filing urgency, and direct versus indirect ownership). The score describes the filing, not future returns. This is not investment advice.
Key facts
- Scoreable Form 4 transactions on record: 161
- Open-market buys: 11
- Sales: 150
- Distinct insiders: 14
- Strongest recent Greediness Score: 94 (Strong)
Primary sources
Related
- Strongest filing
- SOPH in the live feed
- How the Greediness Score works
- What is a cluster buy?
- Form 4 transaction codes
The score describes the filing, not future returns. This is not investment advice.